VOYA Investment Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Buy |
29,369
+313
| +1% | +$4.39K | ﹤0.01% | 1981 |
|
|
2025
Q1 | $454K | Sell |
29,056
-3,080
| -10% | -$48.2K | ﹤0.01% | 1908 |
|
|
2024
Q4 | $448K | Sell |
32,136
-2,472
| -7% | -$34.4K | ﹤0.01% | 1992 |
|
|
2024
Q3 | $322K | Sell |
34,608
-806
| -2% | -$7.5K | ﹤0.01% | 2231 |
|
|
2024
Q2 | $329K | Buy |
35,414
+9,258
| +35% | +$86.1K | ﹤0.01% | 2212 |
|
|
2024
Q1 | $259K | Sell |
26,156
-67,056
| -72% | -$665K | ﹤0.01% | 2329 |
|
|
2023
Q4 | $301K | Buy |
93,212
+54,930
| +143% | +$177K | ﹤0.01% | 2344 |
|
|
2023
Q3 | $203K | Buy |
38,282
+707
| +2% | +$3.75K | ﹤0.01% | 2534 |
|
|
2023
Q2 | $358K | Buy |
37,575
+4,944
| +15% | +$47.1K | ﹤0.01% | 2260 |
|
|
2023
Q1 | $359K | Sell |
32,631
-2,740
| -8% | -$30.1K | ﹤0.01% | 2229 |
|
|
2022
Q4 | $523K | Hold |
35,371
| – | – | ﹤0.01% | 2015 |
|
|
2022
Q3 | $676K | Buy |
35,371
+22,246
| +169% | +$425K | ﹤0.01% | 1840 |
|
|
2022
Q2 | $280K | Buy |
13,125
+2,385
| +22% | +$50.9K | ﹤0.01% | 2214 |
|
|
2022
Q1 | $207K | Hold |
10,740
| – | – | ﹤0.01% | 2348 |
|
|
2021
Q4 | $223K | Sell |
10,740
-39
| -0.4% | -$810 | ﹤0.01% | 2446 |
|
|
2021
Q3 | $258K | Hold |
10,779
| – | – | ﹤0.01% | 2422 |
|
|
2021
Q2 | $294K | Buy |
10,779
+1,343
| +14% | +$36.6K | ﹤0.01% | 2385 |
|
|
2021
Q1 | $273K | Buy |
9,436
+1,003
| +12% | +$29K | ﹤0.01% | 2363 |
|
|
2020
Q4 | $237K | Buy |
+8,433
| New | +$237K | ﹤0.01% | 2334 |
|